pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

6,918 products tracked · 1,486 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 2
certepetide
Bile Duct Cancer (Cholangiocarcinoma)
$LSTALISATA THERAPEUTICS, INC.
0 catalysts
Phase 2
cetrelimab
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
Programmed cell death protein 1
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
cevaretigene ritoparvovec
Leber Congenital Amaurosis (LCA)
$MGTXMeiraGTx Holdings plc
0 catalysts
← prev
page 34 of 50
next →
131
Pain89
Neurology1
Phase 2
cevidoplenib
cevidoplenib [INN]
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
Genosco Inc
0 catalysts
Phase 2
cevostamab
Refractory Multiple Myeloma
Genentech Inc
0 catalysts
Phase 2
ciforadenant
Renal Cell Carcinoma
Adenosine receptor A2a
$CRVSCorvus Pharmaceuticals, Inc.
0 catalysts
Phase 2
ciltistotug
Metastatic Melanoma
Eucure (Beijing) Biopharma Co Ltd
0 catalysts
Phase 2
cinaxadamtase alfa
Adzynma (cinaxadamtase alfa)
Idiopathic Thrombocytopenic Purpura (Immune Thrombocytopenic Purpura)
$TAKTAKEDA PHARMACEUTICAL CO LTD
0 catalysts
Phase 2
cipargamin
cipargamin [INN]
Malaria
$NVSNOVARTIS AG
0 catalysts
Phase 2
ciracigene golparvovec
Canavan Disease
Myrtelle Inc
0 catalysts
Phase 2
claseprubart
claseprubart[INN]
Myasthenia Gravis
Dianthus Therapeutics Inc
0 catalysts
Phase 2
cleminorexton
cleminorexton [INN]
Idiopathic Hypersomnia (IH)
$CNTACentessa Pharmaceuticals plc
0 catalysts
Phase 2
clenbuterol
clenbuterol [INN]
Pompe Disease
$ATXIAVENUE THERAPEUTICS, INC.
0 catalysts
Phase 2
comekibart
comekibart [INN]
Atopic Dermatitis (Atopic Eczema)
Shanghai Mabgeek Biotechnology Co Ltd
0 catalysts
Phase 2
corticorelin
corticorelin [INN]
Peritumoral Brain Edema
Curatis AG
0 catalysts
Phase 2
cusatuzumab
cusatuzumab [INN]
Acute Myelocytic Leukemia (AML, Acute Myeloblastic Leukemia)
OncoVerity Inc
0 catalysts
Phase 2
cutamesine
cutamesine [INN]
Amyotrophic Lateral Sclerosis
Raya Therapeutic Inc
0 catalysts
Phase 2
dabogratinib
dabogratinib [INN]
Achondroplasia
$TYRATyra Biosciences, Inc.
0 catalysts
Phase 2
dactolisib tosylate + everolimus
Respiratory Tract Infections
$ACETAdicet Bio, Inc.
0 catalysts
Phase 2
dantrolene sodium
Ryanodex (dantrolene sodium)
Malignant Hyperthermia
Ryanodine receptor 3Ryanodine receptor 1
Washington University in St Louis
0 catalysts
Phase 2
daretabart
daretabart [INN]
Neuroblastoma
Essential Holdings Ltd
0 catalysts
Phase 2
darinaparsin
Peripheral T-Cell Lymphomas (PTCL)
Solasia Pharma KK
0 catalysts
Phase 2
daznelimgene lisbac
daznelimgene lisbac [INN]
Osteosarcoma
$OSTXOS Therapies Inc
0 catalysts
Phase 2
debamestrocel
Primary Progressive Multiple Sclerosis (PPMS)
$BCLIBRAINSTORM CELL THERAPEUTICS INC.
0 catalysts
Phase 2
deflexifol
Metastatic Colorectal Cancer
FivePhusion Pty Ltd
0 catalysts
Phase 2
delpacibart zotadirsen
Duchenne Muscular Dystrophy
Avidity Biosciences Inc
0 catalysts
Phase 2
dencatistat
dencatistat [INN]
Cutaneous T-Cell Lymphoma
Step Pharma
0 catalysts
Phase 2
denifanstat
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
$SGMTSagimet Biosciences Inc.
0 catalysts
Phase 2
detalimogene voraplasmid
Non Muscle Invasive Bladder Cancer (NMIBC) (Superficial Bladder Cancer)
$ENGNenGene Therapeutics Inc.
0 catalysts
Phase 2
deudomperidone
Diabetic Gastroparesis
CinDome Pharma LLC
0 catalysts